在败血症引起的散布性血管内凝血中,确定抗凝药治疗的预后指标
Toshiaki Iba1, Kazuma Yamakawa2, Yuki Shiko3
1Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-Ku, Tokyo, 113-8421, Japan. toshiiba@juntendo.ac.jp.
Journal of intensive care
|June 24, 2024
概括
一个新的综合预后指数 (CPI) 预测了与败血症相关的散布性血管内凝血 (DIC) 患者接受抗血治疗的28天生存期. 这个简单的工具有助于评估败血症-DIC患者的治疗有效性.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 与败血症相关的扩散性血管内凝血 (DIC) 缺乏可靠的短期治疗效果指标.
- 抗凝药疗法,特别是抗血素缩剂,用于败血症-DIC.
- 预测这些患者的死亡风险对于有效管理至关重要.
研究的目的:
- 开发和验证用于预测28天死亡率的预后指数.
- 确定用抗血素治疗的败血性DIC患者生存的关键预测因素.
- 为临床实践创建一个简单,可计算的工具.
主要方法:
- 来自市场营销后调查的衍生队列和来自全国性败血症登记的验证队列.
- 单变量和多变量分析以确定28天死亡率的独立预测因素.
- 基于DIC分辨率和顺序器官衰竭评估 (SOFA) 评分变化的综合预测指数 (CPI) 的开发,使用接收器操作特征曲线 (AUROC) 分析进行验证.
主要成果:
- DIC分辨率和SOFA分数变化率是死亡率的独立预测指标.
- 开发的综合预测指数 (CPI) 证明了预测能力.
- 生存的AUROC在衍生队列中为0.76,在验证队列中为0.71.
结论:
- 综合预后指数 (CPI) 能够有效地预测接受抗血治疗的败血性DIC患者的28天生存期.
- 消费者消费指数简单,易于计算,并且具有实际的临床实用性.
- 该指数可以帮助临床医生评估预后并指导治疗决策.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
01:24Disorders of Hemostasis
831
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
831
01:09Coagulation
6.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.1K